THE AYAHUASCA’S PSYCHEDELIC COMPONENT DMT POTENTIATES NEURITOGENESIS IN PC12 CELLS
Mariana Pazos, Ignacio Carrera, Giselle Prunell
IBRO Neuroscience Reports October 1, 2023 DOI: 10.1016/j.ibneur.2023.08.605 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Ayahuasca DMT |
| Keywords | Component thermodynamics Mura Hallucinogen |
| Citations | 1 |
| Key findings | Ayahuasca may have therapeutic applications for depression and substance use disorders. |
Abstract
Ayahuasca is a psychedelic beverage originally from the Amazon rainforest used in different shamanic settings for a variety of medicinal, spiritual, and cultural purposes. It is prepared by decoction of the vine Banisteriopsis caapi, source of β-carboline alkaloids, and, Psychotria viridis containing the classic psychedelic N,N-dimethyltryptamine (DMT). As part of the “renaissance of psychedelic studies”, several recent reports highlight its potential therapeutic applications for the treatment of depression and substance use disorders, among others.